"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
(Generic versions may still be available.)
Enlon (edrophonium injection) ® is a short and rapid-acting cholinergic drug. Chemically, edrophonium chloride is ethyl (m-hydroxyphenyl) dimethylammonium chloride.
Each mL contains, in a sterile solution, 10 mg edrophonium chloride compounded with 0.45% phenol as a preservative, and 0.2% sodium sulfite as an antioxidant, buffered with sodium citrate and citric acid, and pH adjusted to approximately 5.4. Structural formula as follows:
Enlon (edrophonium injection) ® is intended for IV and IM use.
What are the possible side effects of edrophonium (Enlon, Tensilon)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:
- slow heart rate;
- chest pain, weak pulse, increased sweating, and dizziness;
- feeling like you might pass out;
- weak or shallow breathing;
- urinating more than usual;
- seizures (convulsions); or
- trouble swallowing.
Less serious side effects (some of which can be expected as...
Last reviewed on RxList: 1/15/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Enlon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.